LIVZON PHARMA (01513) Appoints Li Xiaoyu as Securities Representative

Stock News

Aug 20, 2025

LIVZON PHARMA (01513) announced that the company's board of directors received a resignation letter from securities representative Mr. Ye Delong on August 20, 2025. Due to work adjustments, Mr. Ye Delong will no longer serve as the company's securities representative, with his resignation taking effect from the date it was delivered to the board of directors.

The company's board of directors held the 26th meeting of the 11th board on August 20, 2025, and reviewed and approved the "Proposal on Appointing the Company's Securities Representative." The board agreed to appoint Ms. Li Xiaoyu as the company's securities representative to assist the board secretary in fulfilling relevant duties. Her term of appointment will commence from the date of board approval and continue until the expiration of the company's 11th board of directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1143935924"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143935924\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143935924?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-20 18:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143935924","market":"sh","top_or_hot":-1,"title":"LIVZON PHARMA (01513) Appoints Li Xiaoyu as Securities Representative","media":"Stock News","content":"<p>LIVZON PHARMA (01513) announced that the company's board of directors received a resignation letter from securities representative Mr. Ye Delong on August 20, 2025. Due to work adjustments, Mr. Ye Delong will no longer serve as the company's securities representative, with his resignation taking effect from the date it was delivered to the board of directors.</p>\n<p>The company's board of directors held the 26th meeting of the 11th board on August 20, 2025, and reviewed and approved the \"Proposal on Appointing the Company's Securities Representative.\" The board agreed to appoint Ms. Li Xiaoyu as the company's securities representative to assist the board secretary in fulfilling relevant duties. Her term of appointment will commence from the date of board approval and continue until the expiration of the company's 11th board of directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIVZON PHARMA (01513) Appoints Li Xiaoyu as Securities Representative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIVZON PHARMA (01513) Appoints Li Xiaoyu as Securities Representative\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-20 18:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LIVZON PHARMA (01513) announced that the company's board of directors received a resignation letter from securities representative Mr. Ye Delong on August 20, 2025. Due to work adjustments, Mr. Ye Delong will no longer serve as the company's securities representative, with his resignation taking effect from the date it was delivered to the board of directors.</p>\n<p>The company's board of directors held the 26th meeting of the 11th board on August 20, 2025, and reviewed and approved the \"Proposal on Appointing the Company's Securities Representative.\" The board agreed to appoint Ms. Li Xiaoyu as the company's securities representative to assist the board secretary in fulfilling relevant duties. Her term of appointment will commence from the date of board approval and continue until the expiration of the company's 11th board of directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"161027","symbol_name":"证券","start_time":0,"source_url":"","article_id":"1143935924","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143935924","pubTimestamp":1755684853,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LIVZON PHARMA (01513) announced that the company's board of directors received a resignation letter from securities representative Mr. Ye Delong on August 20, 2025. Due to work adjustments, Mr. Ye...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","01513":"丽珠医药","BK1191":"制药"},"translate_title":"丽珠医药(01513)委任李晓宇为证券代表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"01513":1},"content_text":"LIVZON PHARMA (01513) announced that the company's board of directors received a resignation letter from securities representative Mr. Ye Delong on August 20, 2025. Due to work adjustments, Mr. Ye Delong will no longer serve as the company's securities representative, with his resignation taking effect from the date it was delivered to the board of directors.\nThe company's board of directors held the 26th meeting of the 11th board on August 20, 2025, and reviewed and approved the \"Proposal on Appointing the Company's Securities Representative.\" The board agreed to appoint Ms. Li Xiaoyu as the company's securities representative to assist the board secretary in fulfilling relevant duties. Her term of appointment will commence from the date of board approval and continue until the expiration of the company's 11th board of directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}